The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Technologies needed for tracing engineered biothreats back to their sources are advancing rapidly. Here are some ...
China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should invest ...
The Southeast Asian Regional Center for Graduate Study and Research in Agriculture (Searca) participated in the recent ...
GV20 Therapeutics has reached a milestone in its collaboration with Japan’s Mitsubishi Tanabe Pharma (TSE: 4508), pushing ...
[Asia Economy Reporter Lee Seon-ae] The pharmaceutical and bio industries are rapidly growing. As massive capital concentrates on drug development, technological advancements and industrial progress ...
Once upon a time, Moderna was a shooting star whose success relied on the COVID-19 vaccine, but now advances in an RSV vaccine could mean more success for the pharmaceutical and biotechnology company.
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of ...
Novato is looking to augment its status as a North Bay biotechnology hub under a proposal that could double the footprint of its life sciences campus near Bel Marin Keys. The city’s biotechnology and ...
Vir Biotechnology Inc (NASDAQ:VIR) completed enrollment in Eclipse One, their first registrational phase 3 study for hepatitis Delta, ahead of schedule. The company plans to share a comprehensive data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results